The 2011 Leading Pharmaceutical Companies R&D Expenditures and Major Programs
Global PDF: US$ 3,900.00
For each company, the report provides:
- AstraZeneca
- Bristol-Myers Squibb
- GlaxoSmithKline
- Johnson & Johnson
- Merck
- Novartis
- Pfizer
- Roche
- Sanofi-Aventis
- Wyeth
Contains 160 pages
For each company, the report provides:
- Annual R&D budget.
- Research facilities and staff.
- New technologies, drugs, and indications in development, including their phase and anticipated introduction dates.
- AstraZeneca
- Bristol-Myers Squibb
- GlaxoSmithKline
- Johnson & Johnson
- Merck
- Novartis
- Pfizer
- Roche
- Sanofi-Aventis
- Wyeth
Contains 160 pages